Arcus Biosciences Inc. (RCUS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arcus Biosciences Inc.

    NYSE: RCUS · Real-Time Price · USD
    12.85
    0.48 (3.88%)
    At close: Sep 26, 2025, 3:59 PM
    13.00
    1.17%
    After-hours: Sep 26, 2025, 06:54 PM EDT

    Arcus Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 150M 127M 206M 147.91M
    Short-Term Investments
    		 828M 632M 803M 351.39M
    Long-Term Investments
    		 14M 107M 129M 181.99M
    Other Long-Term Assets
    		 73M 106M 114M 591.19M
    Receivables
    		 25M 42M 43M 745M
    Inventory
    		 n/a n/a -172M -762.44M
    Other Current Assets
    		 13M 30M n/a n/a
    Total Current Assets
    		 1.02B 831M 1.07B 681.3M
    Property-Plant & Equipment
    		 47M 51M 35M 137.42M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 134M 264M 278M 910.6M
    Total Assets
    		 1.15B 1.09B 1.34B 1.59B
    Account Payables
    		 18M 17M 20M 10.26M
    Deferred Revenue
    		 85M 91M 97M 102M
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 14M 39M 48M 5.08M
    Total Current Liabilities
    		 226M 184M 193M 166.08M
    Long-Term Debt
    		 48M n/a n/a n/a
    Other Long-Term Liabilities
    		 391M 142M 140M 5.26M
    Total Long-Term Liabilities
    		 439M 449M 495M 584.36M
    Total Liabilities
    		 665M 633M 688M 750.45M
    Total Debt
    		 60M 11M 120M 116.89M
    Book Value
    		 485M 462M 657M 841.45M
    Book Value Per Share
    		 5.38 6.24 9.13 12.13
    Common Stock
    		 1.62B 1.31B 1.21B 7K
    Retained Earnings
    		 -1.13B -849M -542M -275.35M
    Comprehensive Income
    		 n/a n/a -7M -1.26M
    Shareholders Equity
    		 485M 462M 657M 841.45M
    Total Investments
    		 842M 739M 932M 533.38M

    Add to Watchlist